Company / Total Assets
Cyclerion Therapeutics, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$10.0M
FY2025
5-year range
$10.0M / $59.3M
FY2021-FY2025
Trend
-25.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $13M to $10M over the past 2 years.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of -38.7%.
Declined from $13M to $10M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -18.0%
- 5-Year CAGR
- -38.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -38.7%, indicating a declining trend.
- In FY2025, total assets decreased 25.3% year-over-year.
- Peak total assets was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.0M | -25.3% |
| FY2024 | $13.4M | +0.0% |
| FY2023 | $13.4M | -26.0% |
| FY2022 | $18.1M | -69.5% |
| FY2021 | $59.3M | -48.6% |
| FY2020 | $115.4M | -38.1% |
| FY2019 | $186.5M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026